G protein nucleolar 3 promotes cell-cycle progression and suppresses immune response signaling in castrate-resistant prostate cancer by collaborating with the androgen-receptor

被引：0
|
作者：
Cheung, E. [1 ]
Zhang, C. [1 ]
机构：
[1] Univ Macau, Dept Biomed Sci, Macau, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 211卷
关键词：
D O I：
10.1016/j.ejca.2024.114928
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PB404
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [21] Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression
    R Jin
    H Yamashita
    X Yu
    J Wang
    O E Franco
    Y Wang
    S W Hayward
    R J Matusik
    Oncogene, 2015, 34 : 3700 - 3710
  • [22] Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression
    Jin, R.
    Yamashita, H.
    Yu, X.
    Wang, J.
    Franco, O. E.
    Wang, Y.
    Hayward, S. W.
    Matusik, R. J.
    ONCOGENE, 2015, 34 (28) : 3700 - 3710
  • [23] Plasma Cell-Free DNA (cfDNA) Concentration and Outcomes in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Patients Treated with Androgen Receptor Signalling Inhibitors (ARSIs)
    Fettke, Heidi
    Kwan, Edmond
    Mant, Andrew
    Docanto, Maria
    Bukczynska, Patricia
    To, Sarah
    Waltham, Mark
    Ng, Nicole
    Parente, Phillip
    Pezaro, Carmel
    Azad, Arun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 29 - 29
  • [24] Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells
    Dai, Xiaofan
    Liu, Lingyun
    Liang, Zuowen
    Guo, Kaimin
    Xu, Shengqi
    Wang, Hongliang
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (04) : 712 - 721
  • [25] GALECTIN-3 IS IMPLICATED IN THE PROGRESSION OF CASTRATION-RESISTANT PROSTATE CANCER THROUGH THE REGULATION OF ANGIOGENESIS AND ANDROGEN RECEPTOR SIGNALING
    Fukumori, Tomoharu
    Daizumoto, Kei
    Tsogt-Ochir, Dondoo
    Yamamoto, Yasuyo
    Yamaguchi, Kunihisa
    Takahashi, Masayuki
    Kanayama, Hiro-omi
    JOURNAL OF UROLOGY, 2016, 195 (04): : E1150 - E1150
  • [26] Epigenetic repression of regulator of G-protein signaling 2 promotes androgen-independent prostate cancer cell growth
    Wolff, Dennis W.
    Xie, Yan
    Deng, Caishu
    Gatalica, Zoran
    Yang, Mingjie
    Wang, Bo
    Wang, Jincheng
    Lin, Ming-Fong
    Abel, Peter W.
    Tu, Yaping
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (07) : 1521 - 1531
  • [27] A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression
    Jin, Feng
    Fondell, Joseph D.
    NUCLEIC ACIDS RESEARCH, 2009, 37 (14) : 4826 - 4838
  • [28] SYNERGISTIC TARGETING OF PI3K/AKT-PATHWAY AND ANDROGEN-RECEPTOR AXIS SIGNIFICANTLY DELAYS CASTRATION-RESISTANT PROSTATE CANCER PROGRESSION IN VIVO
    Thomas, Christian
    Lamoureux, Francois
    Crafter, Claire
    Davies, Barry
    Beraldi, Eliana
    Fazli, Ladan
    Kim, Soojin
    Thaper, Daksh
    Gleave, Martin
    Zoubeidi, Amina
    JOURNAL OF UROLOGY, 2013, 189 (04): : E129 - E129
  • [29] Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial
    Roy, Soumyajit
    Sun, Yilun
    Morgan, Scott C.
    Wallis, Christopher J. D.
    King, Kevin
    Zhou, Yu M.
    D'souza, Leah A.
    Azem, Omar
    Cueto-Marquez, Adrianna E.
    Camden, Nathaniel B.
    Spratt, Daniel E.
    Kishan, Amar U.
    Saad, Fred
    Malone, Shawn
    EUROPEAN UROLOGY, 2023, 83 (06) : 571 - 579
  • [30] Loss of Androgen Receptor Expression Promotes a Stem-like Cell Phenotype in Prostate Cancer through STAT3 Signaling
    Schroeder, Anne
    Herrmann, Andreas
    Cherryholmes, Gregory
    Kowolik, Claudia
    Buettner, Ralf
    Pal, Sumanta
    Yu, Hua
    Mueller-Newen, Gerhard
    Jove, Richard
    CANCER RESEARCH, 2014, 74 (04) : 1227 - 1237
12345